NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ConnectOne Bancorp, Inc. (NASDAQ:CNOB), Rockwell Medical, Inc. (NASDAQ:RMTI), Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), Renasant Corporation (NASDAQ:RNST), and Natera, Inc. (NASDAQ:NTRA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CNOB DOWNLOAD: http://Fundamental-Markets.com/register/?so=CNOB
RMTI DOWNLOAD: http://Fundamental-Markets.com/register/?so=RMTI
AXDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AXDX
EBIO DOWNLOAD: http://Fundamental-Markets.com/register/?so=EBIO
RNST DOWNLOAD: http://Fundamental-Markets.com/register/?so=RNST
NTRA DOWNLOAD: http://Fundamental-Markets.com/register/?so=NTRA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ConnectOne Bancorp, Inc. (NASDAQ:CNOB), Rockwell Medical, Inc. (NASDAQ:RMTI), Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), Renasant Corporation (NASDAQ:RNST), and Natera, Inc. (NASDAQ:NTRA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 4th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CONNECTONE BANCORP, INC. (CNOB) REPORT OVERVIEW

ConnectOne's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, ConnectOne reported interest income of $46.34MM vs $41.18MM (up 12.53%) and basic earnings per share $0.41 vs $0.39 (up 5.13%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, ConnectOne reported interest income of $161.24MM vs $140.97MM (up 14.38%) and basic earnings per share $1.02 vs $1.37 (down 25.55%). ConnectOne is expected to report earnings on January 25th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $1.86 and is expected to report on January 25th, 2018.

To read the full ConnectOne Bancorp, Inc. (CNOB) report, download it here: http://Fundamental-Markets.com/register/?so=CNOB

-----------------------------------------

ROCKWELL MEDICAL, INC. (RMTI) REPORT OVERVIEW

Rockwell Medical's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Rockwell Medical reported revenue of $14.63MM vs $12.81MM (up 14.14%) and basic earnings per share -$0.10 vs -$0.09. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Rockwell Medical reported revenue of $53.28MM vs $55.35MM (down 3.73%) and basic earnings per share -$0.39 vs -$0.29. Rockwell Medical is expected to report earnings on March 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.10. The estimated EPS forecast for the next fiscal year is -$0.36 and is expected to report on March 21st, 2018.

To read the full Rockwell Medical, Inc. (RMTI) report, download it here: http://Fundamental-Markets.com/register/?so=RMTI

-----------------------------------------

ACCELERATE DIAGNOSTICS, INC. (AXDX) REPORT OVERVIEW

Accelerate Diagnostics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Accelerate Diagnostics reported revenue of $0.83MM vs $0.02MM (up 3,350.00%) and basic earnings per share -$0.31 vs -$0.34. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Accelerate Diagnostics reported revenue of $0.25MM vs $0.15MM (up 67.35%) and basic earnings per share -$1.29 vs -$1.01. Accelerate Diagnostics is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$1.21 and is expected to report on February 26th, 2018.

To read the full Accelerate Diagnostics, Inc. (AXDX) report, download it here: http://Fundamental-Markets.com/register/?so=AXDX

-----------------------------------------

ELEVEN BIOTHERAPEUTICS, INC. (EBIO) REPORT OVERVIEW

Eleven Biotherapeutics' Recent Financial Performance

For the twelve months ended December 31st, 2016 vs December 31st, 2015, Eleven Biotherapeutics reported revenue of $29.98MM vs $0.99MM (up 2,928.38%) and basic earnings per share $0.09 vs -$1.76. Eleven Biotherapeutics is expected to report earnings on March 23rd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.20.

To read the full Eleven Biotherapeutics, Inc. (EBIO) report, download it here: http://Fundamental-Markets.com/register/?so=EBIO

-----------------------------------------

RENASANT CORPORATION (RNST) REPORT OVERVIEW

Renasant's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Renasant reported interest income of $100.70MM vs $83.03MM (up 21.27%) and basic earnings per share $0.54 vs $0.55 (down 1.82%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Renasant reported interest income of $329.14MM vs $263.02MM (up 25.14%) and basic earnings per share $2.18 vs $1.89 (up 15.34%). Renasant is expected to report earnings on January 16th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $2.87 and is expected to report on January 16th, 2018.

To read the full Renasant Corporation (RNST) report, download it here: http://Fundamental-Markets.com/register/?so=RNST

-----------------------------------------

NATERA, INC. (NTRA) REPORT OVERVIEW

Natera's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Natera reported revenue of $56.66MM vs $53.89MM (up 5.13%) and basic earnings per share -$0.51 vs -$0.50. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Natera reported revenue of $217.07MM vs $190.36MM (up 14.04%) and basic earnings per share -$1.86 vs -$2.68. Natera is expected to report earnings on March 6th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.72. The estimated EPS forecast for the next fiscal year is -$1.31 and is expected to report on March 6th, 2018.

To read the full Natera, Inc. (NTRA) report, download it here: http://Fundamental-Markets.com/register/?so=NTRA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.